Education
About Us
Working with TipRanks
Follow Us
Q-linea AB (DE:3F8)
FRANKFURT:3F8
3F8 Stock Chart & Stats
Day’s Range― - ―
52-Week Range<€0.01 - €0.05
Previous CloseN/A
Volume9.40K
Average Volume (3M)3.36K
Market Cap
€28.70M
Enterprise ValueN/A
Total Cash (Recent Filing)€68.03M
Total Debt (Recent Filing)kr51.09M
Price to Earnings (P/E)―
Beta104.03
Next Earnings
Jul 10, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding6,430,039,600
10 Day Avg. Volume2,517
30 Day Avg. Volume3,360
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.71
Price to Sales (P/S)0.00
P/FCF Ratio-1.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Q-linea AB News
PremiumCompany Announcements
Q-linea AB Expands Share Capital with New Issuance
PremiumCompany Announcements
Q-linea AB Proposes Reverse Share Split and Capital Reduction
PremiumCompany Announcements
Q-linea AB Announces 2025 Annual General Meeting and Key Resolutions
PremiumCompany Announcements
Q-linea AB Successfully Exercises Series TO1 Warrants
PremiumCompany Announcements
Q-linea AB Concludes Trading in Warrants Series TO 1
PremiumCompany Announcements
Q-linea AB Announces Board Member Nominations for 2025
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
3F8 FAQ
What was Q-linea AB’s price range in the past 12 months?
Q-linea AB lowest stock price was <€0.01 and its highest was €0.05 in the past 12 months.
What is Q-linea AB’s market cap?
Q-linea AB’s market cap is €28.70M.
When is Q-linea AB’s upcoming earnings report date?
Q-linea AB’s upcoming earnings report date is Jul 10, 2025 which is in 33 days.
How were Q-linea AB’s earnings last quarter?
Q-linea AB released its earnings results on Apr 14, 2025. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is Q-linea AB overvalued?
According to Wall Street analysts Q-linea AB’s price is currently Overvalued.
Does Q-linea AB pay dividends?
Q-linea AB does not currently pay dividends.
What is Q-linea AB’s EPS estimate?
Q-linea AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Q-linea AB have?
Q-linea AB has 6,430,039,600 shares outstanding.
What happened to Q-linea AB’s price movement after its last earnings report?
Q-linea AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Q-linea AB?
Currently, no hedge funds are holding shares in DE:3F8
Company Description
Q-linea AB
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions for healthcare providers. Q-linea AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.
Technical Analysis
SciBase Holding AB
―
Clinical Laserthermia Systems AB Class B
―
SpectraCure AB
―
Luxbright AB
―
Acarix AB
―